New Tools for Prostate Cancer Research
By Biotechdaily staff writers
Posted on 08 Apr 2004
Researchers in the field of prostate cancer now have access to six new cell lines that could prove to be important tools in the effort to understand and combat this major disease of older men throughout the world.Posted on 08 Apr 2004
The cell lines are the result of a two-year collaboration between Asterand (Detroit, MI, USA), a major tissue bank operator, and Onyvax Ltd. (London, UK), a company that is developing vaccines for prostate and other cancers.
"These new lines are important because they effectively double the material available to researchers,” explained Dr. James Eliason, head of research for Asterand. "Until now there have been only three prostate cancer lines commonly available for study. Each cell line represents a single patient and every patient is different so it is useful to examine different lines. Now we are offering three lines representing the disease plus three cell lines representing normal prostate tissue.”
Related Links:
Asterand
Onyvax
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Urine Analyzer
respons® UDS100
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
